NEW YORK (360Dx) – Chembio Diagnostics said today that it has received a commitment from Bio-Manguinhos for the purchase of $8.5 million worth of materials related to its HIV and Leishmania point-of-care immunoassays.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.